Stock 600080 GINWA ENTERPRISE (GROUP) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ginwa Enterprise (Group) Inc.

Equities

600080

CNE000000QQ8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7.12 CNY +1.57% Intraday chart for Ginwa Enterprise (Group) Inc. +5.64% -4.43%
Apr. 26 Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Ginwa Enterprise Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,673 2,251 2,087 3,184 2,915 2,781
Enterprise Value (EV) 1 2,164 1,823 1,443 2,533 2,351 2,114
P/E ratio 66.5 x 82.9 x 52.8 x -175 x 87.2 x -64.8 x
Yield 0.56% 0.5% 1.61% - - -
Capitalization / Revenue 3.59 x 2.98 x 3.12 x 5.96 x 5.03 x 4.92 x
EV / Revenue 2.9 x 2.42 x 2.16 x 4.74 x 4.06 x 3.74 x
EV / EBITDA 40.4 x 41.2 x 48.3 x 70.6 x 76.2 x 78.7 x
EV / FCF -62 x -31.6 x 7.56 x 114 x -7.48 x -170 x
FCF Yield -1.61% -3.16% 13.2% 0.88% -13.4% -0.59%
Price to Book 1.51 x 1.31 x 1.21 x 1.92 x 1.73 x 1.71 x
Nbr of stocks (in thousands) 373,270 373,270 373,270 373,270 373,270 373,270
Reference price 2 7.160 6.030 5.590 8.530 7.810 7.450
Announcement Date 4/19/19 4/29/20 4/22/21 4/21/22 4/27/23 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 745.2 754.5 668.2 534 579.4 565.4
EBITDA 1 53.51 44.27 29.9 35.88 30.84 26.87
EBIT 1 27.91 19.13 2.594 8.513 4.498 -5.754
Operating Margin 3.75% 2.53% 0.39% 1.59% 0.78% -1.02%
Earnings before Tax (EBT) 1 42.16 41.76 46.26 -23.73 47.9 -41.05
Net income 1 38.32 25.9 37.74 -18.16 33.46 -42.89
Net margin 5.14% 3.43% 5.65% -3.4% 5.78% -7.59%
EPS 2 0.1076 0.0727 0.1059 -0.0487 0.0896 -0.1149
Free Cash Flow 1 -34.92 -57.68 191 22.18 -314.2 -12.41
FCF margin -4.69% -7.64% 28.59% 4.15% -54.23% -2.19%
FCF Conversion (EBITDA) - - 638.8% 61.81% - -
FCF Conversion (Net income) - - 506.14% - - -
Dividend per Share 2 0.0400 0.0300 0.0900 - - -
Announcement Date 4/19/19 4/29/20 4/22/21 4/21/22 4/27/23 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 508 428 643 651 564 667
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -34.9 -57.7 191 22.2 -314 -12.4
ROE (net income / shareholders' equity) 2.55% 1.51% 2.15% -1.08% 2% -2.58%
ROA (Net income/ Total Assets) 1.03% 0.6% 0.08% 0.28% 0.15% -0.18%
Assets 1 3,728 4,285 45,854 -6,535 22,886 24,356
Book Value Per Share 2 4.750 4.590 4.610 4.440 4.510 4.360
Cash Flow per Share 2 0.9600 0.8000 0.9900 0.4300 1.160 1.650
Capex 1 6.26 63.5 10.3 12 299 69.1
Capex / Sales 0.84% 8.41% 1.55% 2.25% 51.58% 12.22%
Announcement Date 4/19/19 4/29/20 4/22/21 4/21/22 4/27/23 4/26/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
GINWA ENTERPRISE (GROUP) INC. Stock Ginwa Enterprise (Group) Inc.
-4.43% 367M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.10% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.42% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.21% 194B
PFIZER, INC. Stock Pfizer, Inc.
-5.59% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600080 Stock
  4. Financials Ginwa Enterprise (Group) Inc.